EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Immunomodulatory Role of Vitamin D in Obesity

Wiktoria Górecka, Jakub Dudek, Aleksandra Dudek, Wiktoria Józefowicz, Dorota Szydłowska

Biuletyn Głównej Biblioteki Lekarskiej · 01.06.2026 · 59 (386) · 17-32

DOI: 10.2478/bgbl-2026-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biuletyn Głównej Biblioteki Lekarskiej, online erschienen am 20.05.2026. Verfasst von Wiktoria Górecka und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is fundamentally characterized by low-grade chronic inflammation (LGCI), driven by hypertrophic adipocytes and macrophage infiltration that release pro-inflammatory cytokines (e.g., TNF-α, IL-6). Vitamin D, recognized as a potent immunomodulator, holds significant potential in mitigating this inflammatory cascade. This review evaluates the impact of vitamin D supplementation on the pro-inflammatory cytokine profile and metabolic parameters in patients with obesity and metabolic syndrome.

Methods

A comprehensive literature review was conducted using PubMed and Google Scholar databases. The analysis encompassed 31 scientific articles, including recent meta-analyses and randomized controlled trials (RCTs), focusing on the interplay between vitamin D, systemic inflammation, and obesity-related metabolic disturbances.

Results

Current evidence indicates that vitamin D supplementation significantly reduces systemic inflammatory markers (IL-6, hs-CRP, TNF-α) and improves insulin resistance indices (HOMA-IR) and lipid profiles. However, supplementation alone does not induce significant reductions in body mass index (BMI) or total adipose tissue volume. Furthermore, owing to vitamin D sequestration in adipose tissue and volumetric dilution, patients with obesity require personalized, high-dose regimens (often ≥4,000 IU/day) to achieve optimal serum 25(OH)D levels (30–50 ng/mL) necessary for clinical immunomodulation.

Conclusions

While vitamin D is not a standalone weight-loss intervention, it serves as a crucial adjunctive therapy for modulating the LGCI associated with obesity. Current data do not support extrapolating these anti-inflammatory effects to a definitive reduction in cardiometabolic risk. However, achieving optimal serum levels requires personalized dosing to address altered pharmacokinetics, alongside essential lifestyle modifications, including diet and exercise.

Zitieren

APA

Górecka, W., Dudek, J., Dudek, A., Józefowicz, W., & Szydłowska, D. (2026). The Immunomodulatory Role of Vitamin D in Obesity. Biuletyn Głównej Biblioteki Lekarskiej, 59(386), 17-32. https://doi.org/10.2478/bgbl-2026-0002

Vancouver

Górecka W, Dudek J, Dudek A, Józefowicz W, Szydłowska D. The Immunomodulatory Role of Vitamin D in Obesity. Biuletyn Głównej Biblioteki Lekarskiej. 2026;59(386):17-32. doi:10.2478/bgbl-2026-0002

BibTeX
@article{Grecka2026,
  author = {Górecka, Wiktoria and Dudek, Jakub and Dudek, Aleksandra and Józefowicz, Wiktoria and Szydłowska, Dorota},
  title = {The Immunomodulatory Role of Vitamin D in Obesity},
  journal = {Biuletyn Głównej Biblioteki Lekarskiej},
  year = {2026},
  volume = {59},
  number = {386},
  pages = {17--32},
  doi = {10.2478/bgbl-2026-0002}
}
Kostenlos starten →